便携式手持即时检测与实验室胆红素定量在新生儿中的诊断准确性:系统综述与Meta分析
该系统综述与Meta分析纳入10项研究共3122例0-28天新生儿,比较便携式手持即时检测设备与实验室胆红素定量的诊断准确性。合并分析显示总胆红素平均差异为-14 μmol/L(95% CBs -106至78),Bilistick平均差异为-17 μmol/L(95% CBs -114至80)。即时检测设备出结果更快、需血量更少,但Bilistick定量失败可能性更高,测量不精密度需改进以指导新生儿黄疸管理。
要点
- 便携式即时检测设备与实验室胆红素定量相比,合并平均差异为-14 μmol/L,95% CBs为-106至78 μmol/L。
- Bilistick亚组平均差异为-17 μmol/L(95% CBs -114至80 μmol/L),且定量失败可能性高于实验室检测。
- 即时检测设备出结果更快、需血量更少,但测量不精密度需改进以用于新生儿黄疸管理。
核心结论
- 尽管手持即时检测设备具有优势,但新生儿胆红素测量不精密度需改进以指导黄疸管理。
研究设计与样本
- 系统综述与Meta分析,检索6个电子数据库至2022年12月5日,纳入10项研究(9项横断面研究、1项前瞻性队列研究),共3122例0-28天新生儿。
主要发现
- 3122对配对测量显示总胆红素合并平均差异为-14 μmol/L,合并95% CBs为-106至78 μmol/L。
- Bilistick的合并平均差异为-17 μmol/L(95% CBs,-114至80 μmol/L)。
- 即时检测设备出结果比实验室胆红素定量更快,所需血量更少。
- Bilistick相比实验室胆红素定量更可能出现定量失败。
临床怎么用
- 临床使用手持即时检测设备时需考虑其与实验室定量的平均差异及较宽的一致性界限,谨慎解读胆红素结果。
局限性
- 纳入的10项研究中有3项被认为存在高偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Quantification of bilirubin in blood is essential for early diagnosis and timely treatment of neonatal hyperbilirubinemia. Handheld point-of-care (POC) devices may overcome the current issues with conventional laboratory-based bilirubin (LBB) quantification. OBJECTIVE: To systematically evaluate the reported diagnostic accuracy of POC devices compared with LBB quantification. DATA SOURCES: A systematic literature search was conducted in 6 electronic databases (Ovid MEDLINE, Embase, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, CINAHL, and Google Scholar) up to December 5, 2022. STUDY SELECTION: Studies were included in this systematic review and meta-analysis if they had a prospective cohort, retrospective cohort, or cross-sectional design and reported on the comparison between POC device(s) and LBB quantification in neonates aged 0 to 28 days. Point-of-care devices needed the following characteristics: portable, handheld, and able to provide a result within 30 minutes. This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline. DATA EXTRACTION AND SYNTHESIS: Data extraction was performed by 2 independent reviewers into a prespecified, customized form. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Meta-analysis was performed of multiple Bland-Altman studies using the Tipton and Shuster method for the main outcome. MAIN OUTCOMES AND MEASURES: The main outcome was mean difference and limits of agreement in bilirubin levels between POC device and LBB quantification. Secondary outcomes were (1) turnaround time (TAT), (2) blood volumes, and (3) percentage of failed quantifications. RESULTS: Ten studies met the inclusion criteria (9 cross-sectional studies and 1 prospective cohort study), representing 3122 neonates. Three studies were considered to have a high risk of bias. The Bilistick was evaluated as the index test in 8 studies and the BiliSpec in 2. A total of 3122 paired measurements showed a pooled mean difference in total bilirubin levels of -14 μmol/L, with pooled 95% CBs of -106 to 78 μmol/L. For the Bilistick, the pooled mean difference was -17 μmol/L (95% CBs, -114 to 80 μmol/L). Point-of-care devices were faster in returning results compared with LBB quantification, whereas blood volume needed was less. The Bilistick was more likely to have a failed quantification compared with LBB. CONCLUSIONS AND RELEVANCE: Despite the advantages that handheld POC devices offer, these findings suggest that the imprecision for measurement of neonatal bilirubin needs improvement to tailor neonatal jaundice management.
引用
- Westenberg LEH, Been JV, Willemsen SP, et al. Diagnostic Accuracy of Portable, Handheld Point-of-Care Tests vs Laboratory-Based Bilirubin Quantification in Neonates: A Systematic Review and Meta-analysis. JAMA Pediatr. 2023. PMID: 36912856. doi:10.1001/jamapediatrics.2023.0059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。